Delivery Order SPE2DB24D1205-SPE2DB25FCVUT

Award Date 4/11/25
Potential Completion Date 4/14/25
Potential Value $4.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $5,541.77 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,561,368,550 units of JANUMET 50-1,000 mg tablets, a medication used to treat type 2 diabetes. The order has a completion date of June 29, 2023 and was awarded on June 28, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,028.70, is for the supply of JANUMET 50-1,000 MG tablets. It has a completion date of June 8, 2023 and is a firm-fixed price contract. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a $23,562.48 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation. The contract is for the supply of 4,565,632,210 units of the pharmaceutical product JANUMET 50-1,000 MG TABLET 180S. The contract has an ultimate completion date of August 30, 2024. AmerisourceBergen Drug Corporation is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and this contract supports the...
This federal contract award, valued at $1,136.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a medication used for the treatment of diabetes. The contract has an ultimate completion date of March 31, 2025 and is a firm fixed-price delivery order. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,044.44, is for the supply of JANUMET 50-1,000 MG TABLET 180S, a diabetes medication. The contract has a firm fixed-price pricing structure and a completion date of May 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $8,063.20 firm fixed-price contract is for the supply of 4565952821 - JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract has an ultimate completion date of September 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,541.65, is for the supply of JANUMET 50-1,000 MG TABLET 180S, a type of medication. The contract is a firm fixed price, Delivery Order arrangement, with an ultimate completion date of March 12, 2024. The contract was not designated as a set-aside. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product, with a ceiling value of $4,076.51 and a completion date of March 6, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $7,432.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product, with a completion date of February 7, 2024. The contract is a firm fixed-price arrangement, with no set-aside designation indicated. Amerisourcebergen Drug Corp is the prime contractor, and...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,451.56 firm fixed-price delivery order is for JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract has an ultimate completion date of April 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCVUT
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,836.85, is for the delivery of 4,567,884,834 units of the drug JANUMET 50-1,000 MG TABLET 1000S. The contract has a firm-fixed price and an ultimate completion date of April 14, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen Drug Corp holds with the DLA, valued at $999,999,999 and running through November 2026, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/11/25, 10:09 AM